Correlation Between Inhibrx Biosciences, and ScanTech

Can any of the company-specific risk be diversified away by investing in both Inhibrx Biosciences, and ScanTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx Biosciences, and ScanTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx Biosciences, and ScanTech AI Systems, you can compare the effects of market volatilities on Inhibrx Biosciences, and ScanTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx Biosciences, with a short position of ScanTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx Biosciences, and ScanTech.

Diversification Opportunities for Inhibrx Biosciences, and ScanTech

-0.6

Correlation Coefficient

Inhibrx Biosciences,  ScanTech

Excellent diversification

The 3 months correlation between Inhibrx and ScanTech is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx Biosciences, and ScanTech AI Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ScanTech AI Systems and Inhibrx Biosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx Biosciences, are associated (or correlated) with ScanTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ScanTech AI Systems has no effect on the direction of Inhibrx Biosciences, i.e., Inhibrx Biosciences, and ScanTech go up and down completely randomly.

Pair Corralation between Inhibrx Biosciences, and ScanTech

Given the investment horizon of 90 days Inhibrx Biosciences, is expected to generate 0.83 times more return on investment than ScanTech. However, Inhibrx Biosciences, is 1.2 times less risky than ScanTech. It trades about 0.25 of its potential returns per unit of risk. ScanTech AI Systems is currently generating about -0.26 per unit of risk. If you would invest  1,216  in Inhibrx Biosciences, on April 23, 2025 and sell it today you would earn a total of  996.00  from holding Inhibrx Biosciences, or generate 81.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Inhibrx Biosciences,  vs.  ScanTech AI Systems

Inhibrx Biosciences,

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx Biosciences, are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental drivers, Inhibrx Biosciences, showed solid returns over the last few months and may actually be approaching a breakup point.

ScanTech AI Systems

Risk-Adjusted Performance

Very Weak

Over the last 90 days ScanTech AI Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Inhibrx Biosciences, and ScanTech

The main advantage of trading using opposite Inhibrx Biosciences, and ScanTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx Biosciences, position performs unexpectedly, ScanTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ScanTech will offset losses from the drop in ScanTech's long position.

The idea behind Inhibrx Biosciences, and ScanTech AI Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..